DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Ridker PM. et al.
Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.
Circulation 2012;
126: 2739-2748.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.